GlassScriptPhysician profile
Thomas O Carpenter
NPI 1730162553
$92,937.74
in general payments reported to CMS, 2019-2025
13 companies · $7,929 in 2025
The $7,929 reported for 2025 was more than what 87% of Pediatric Endocrinology providers received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24K · 2020: $1,315 · 2021: $12K · 2022: $3,960 · 2023: $27K · 2024: $17K · 2025: $7,929.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $49K · Travel and Lodging: $2,722 · Food and Beverage: $833.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $48,701.24 |
| Travel and Lodging | $2,721.90 |
| Food and Beverage | $832.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kyowa Kirin, INC. | $39,895.79 | 2022-2025 | Crysvita |
| Ultragenyx Pharmaceutical INC. | $37,406.03 | 2019-2024 | |
| Kyowa Kirin Services LTD | $7,537.50 | 2021 | |
| Regeneron Pharmaceuticals, INC. | $3,096.81 | 2019-2020 | |
| Alexion Pharmaceuticals, INC. | $1,575.00 | 2021 | |
| Ipsen Bioscience INC. | $1,500.00 | 2021-2022 | |
| Biomarin Pharmaceutical INC. | $1,368.74 | 2025 | |
| Mirum Pharmaceuticals, INC. | $500.00 | 2025 | |
| Tandem Diabetes Care, INC. | $42.54 | 2019 | |
| Companion Medical, INC. | $15.33 | 2020 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Carpenter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.